Cargando…
Integration of magnetic resonance imaging into prostate cancer nomograms
The decision whether to undergo prostate biopsy must be carefully weighed. Nomograms have widely been utilized as risk calculators to improve the identification of prostate cancer by weighing several clinical factors. The recent inclusion of multiparametric magnetic resonance imaging (mpMRI) finding...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109484/ https://www.ncbi.nlm.nih.gov/pubmed/35586139 http://dx.doi.org/10.1177/17562872221096386 |
_version_ | 1784708909307527168 |
---|---|
author | Brinkley, Garrett J. Fang, Andrew M. Rais-Bahrami, Soroush |
author_facet | Brinkley, Garrett J. Fang, Andrew M. Rais-Bahrami, Soroush |
author_sort | Brinkley, Garrett J. |
collection | PubMed |
description | The decision whether to undergo prostate biopsy must be carefully weighed. Nomograms have widely been utilized as risk calculators to improve the identification of prostate cancer by weighing several clinical factors. The recent inclusion of multiparametric magnetic resonance imaging (mpMRI) findings into nomograms has drastically improved their nomogram’s accuracy at identifying clinically significant prostate cancer. Several novel nomograms have incorporated mpMRI to aid in the decision-making process in proceeding with a prostate biopsy in patients who are biopsy-naïve, have a prior negative biopsy, or are on active surveillance. Furthermore, novel nomograms have incorporated mpMRI to aid in treatment planning of definitive therapy. This literature review highlights how the inclusion of mpMRI into prostate cancer nomograms has improved upon their performance, potentially reduce unnecessary procedures, and enhance the individual risk assessment by improving confidence in clinical decision-making by both patients and their care providers. |
format | Online Article Text |
id | pubmed-9109484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-91094842022-05-17 Integration of magnetic resonance imaging into prostate cancer nomograms Brinkley, Garrett J. Fang, Andrew M. Rais-Bahrami, Soroush Ther Adv Urol Current Best Practice for Prostate Biopsy: What is the evidence? The decision whether to undergo prostate biopsy must be carefully weighed. Nomograms have widely been utilized as risk calculators to improve the identification of prostate cancer by weighing several clinical factors. The recent inclusion of multiparametric magnetic resonance imaging (mpMRI) findings into nomograms has drastically improved their nomogram’s accuracy at identifying clinically significant prostate cancer. Several novel nomograms have incorporated mpMRI to aid in the decision-making process in proceeding with a prostate biopsy in patients who are biopsy-naïve, have a prior negative biopsy, or are on active surveillance. Furthermore, novel nomograms have incorporated mpMRI to aid in treatment planning of definitive therapy. This literature review highlights how the inclusion of mpMRI into prostate cancer nomograms has improved upon their performance, potentially reduce unnecessary procedures, and enhance the individual risk assessment by improving confidence in clinical decision-making by both patients and their care providers. SAGE Publications 2022-05-13 /pmc/articles/PMC9109484/ /pubmed/35586139 http://dx.doi.org/10.1177/17562872221096386 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Current Best Practice for Prostate Biopsy: What is the evidence? Brinkley, Garrett J. Fang, Andrew M. Rais-Bahrami, Soroush Integration of magnetic resonance imaging into prostate cancer nomograms |
title | Integration of magnetic resonance imaging into prostate cancer
nomograms |
title_full | Integration of magnetic resonance imaging into prostate cancer
nomograms |
title_fullStr | Integration of magnetic resonance imaging into prostate cancer
nomograms |
title_full_unstemmed | Integration of magnetic resonance imaging into prostate cancer
nomograms |
title_short | Integration of magnetic resonance imaging into prostate cancer
nomograms |
title_sort | integration of magnetic resonance imaging into prostate cancer
nomograms |
topic | Current Best Practice for Prostate Biopsy: What is the evidence? |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109484/ https://www.ncbi.nlm.nih.gov/pubmed/35586139 http://dx.doi.org/10.1177/17562872221096386 |
work_keys_str_mv | AT brinkleygarrettj integrationofmagneticresonanceimagingintoprostatecancernomograms AT fangandrewm integrationofmagneticresonanceimagingintoprostatecancernomograms AT raisbahramisoroush integrationofmagneticresonanceimagingintoprostatecancernomograms |